Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Paul Rutherford Carter. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Paul Rutherford Carter har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:MNKPF / Mallinckrodt Plc - New | Director | 0 |
US:ALDR / Alder BioPharmaceuticals, Inc. | Director | 0 |
US:GILD / Gilead Sciences, Inc. | EVP Commercial Ops | 26 043 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Paul Rutherford Carter. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Paul Rutherford Carter som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-21 |
|
4 | MNKPF |
Mallinckrodt plc
Ordinary Shares |
D - Sale to Issuer | −20 320 | 0 | −100,00 | ||||
2020-05-15 |
|
4 | MNK |
Mallinckrodt plc
Ordinary Shares |
F - Taxes | −9 117 | 20 320 | −30,97 | 2,96 | −26 986 | 60 147 | |
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −22 500 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −30 000 | 0 | −100,00 | ||||
2019-05-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 22 500 | 22 500 | |||||
2019-05-17 |
|
4 | MNK |
Mallinckrodt plc
Ordinary Shares |
A - Award | 19 396 | 29 437 | 193,17 | ||||
2019-05-17 |
|
4 | MNK |
Mallinckrodt plc
Ordinary Shares |
F - Taxes | −8 906 | 10 041 | −47,00 | 15,21 | −135 460 | 152 724 | |
2018-05-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2018-05-18 |
|
4 | MNK |
Mallinckrodt plc
Ordinary Shares |
A - Award | 18 947 | 18 947 | |||||
2017-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −183 | 26 043 | −0,70 | |||
2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 817 | 4 803 | −27,45 | |||
2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 62 305 | −3,11 | 79,81 | −159 620 | 4 972 562 | |
2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 183 | 64 305 | 0,29 | 24,90 | 4 558 | 1 601 516 |
2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 1 817 | 64 122 | 2,92 | 40,56 | 73 698 | 2 600 788 |
2016-08-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −2 500 | 2 500 | −50,00 | ||||
2016-08-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −1 317 | 62 305 | −2,07 | 79,47 | −104 662 | 4 951 378 | |
2016-08-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 500 | 63 622 | 4,09 | ||||
2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 26 226 | −7,09 | |||
2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 61 122 | −3,17 | 83,12 | −166 250 | 5 080 754 | |
2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 000 | 63 122 | 3,27 | 24,90 | 49 810 | 1 572 053 |
2016-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 28 226 | −6,62 | |||
2016-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 61 122 | −3,17 | 87,02 | −174 040 | 5 318 843 | |
2016-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 000 | 63 122 | 3,27 | 24,90 | 49 810 | 1 572 053 |
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −3 865 | 16 906 | −18,61 | |||
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 795 | 0 | −100,00 | |||
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −4 232 | 30 226 | −12,28 | |||
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −43 200 | 0 | −100,00 | |||
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −57 092 | 61 122 | −48,30 | 86,85 | −4 958 600 | 5 308 617 | |
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 3 865 | 118 214 | 3,38 | 80,65 | 311 712 | 9 533 959 |
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 795 | 114 349 | 5,34 | 80,65 | 467 367 | 9 222 247 |
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 4 232 | 108 554 | 4,06 | 24,90 | 105 398 | 2 703 537 |
2016-06-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 43 200 | 104 322 | 70,68 | 24,30 | 1 049 544 | 2 534 503 |
2016-06-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −183 | 34 458 | −0,53 | |||
2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 817 | 6 620 | −21,54 | |||
2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 61 122 | −3,17 | 88,72 | −177 448 | 5 422 982 | |
2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 183 | 63 122 | 0,29 | 24,90 | 4 558 | 1 572 053 |
2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 1 817 | 62 939 | 2,97 | 40,56 | 73 698 | 2 552 806 |
2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 34 641 | −5,46 | |||
2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 61 122 | −3,17 | 91,34 | −182 680 | 5 582 883 | |
2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 000 | 63 122 | 3,27 | 24,90 | 49 810 | 1 572 053 |
2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 36 641 | −5,18 | |||
2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 61 122 | −3,17 | 87,90 | −175 800 | 5 372 624 | |
2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 63 122 | 3,27 | 24,90 | 49 810 | 1 572 053 | |
2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −7 395 | 61 122 | −10,79 | 91,15 | −674 054 | 5 571 270 | |
2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 9 554 | 68 517 | 16,20 | ||||
2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 9 932 | 58 963 | 20,26 | ||||
2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 248 | 49 031 | 0,51 | 76,02 | 18 854 | 3 727 533 | |
2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
A - Award | 42 880 | 42 880 | |||||
2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 818 | 8 437 | −17,73 | |||
2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −182 | 38 641 | −0,47 | |||
2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 48 783 | −3,94 | 82,32 | −164 640 | 4 015 817 | |
2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 818 | 50 783 | 3,71 | 40,56 | 73 738 | 2 059 758 | |
2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 182 | 48 965 | 0,37 | 24,90 | 4 533 | 1 219 473 | |
2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −823 | 0 | −100,00 | |||
2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 177 | 38 823 | −2,94 | |||
2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 48 783 | −3,94 | 99,20 | −198 400 | 4 839 274 | |
2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 177 | 50 783 | 2,37 | 24,90 | 29 313 | 1 264 751 | |
2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 823 | 49 606 | 1,69 | 26,99 | 22 213 | 1 338 866 | |
2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 823 | −70,85 | |||
2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 48 783 | −3,94 | 106,38 | −212 760 | 5 189 536 | |
2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 50 783 | 4,10 | 26,99 | 53 980 | 1 370 633 | |
2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 816 | 10 255 | −15,04 | |||
2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −184 | 2 823 | −6,12 | |||
2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 48 783 | −3,94 | 108,36 | −216 712 | 5 285 931 | |
2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | −1 816 | 50 783 | −3,45 | 40,56 | −73 657 | 2 059 758 | |
2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | −184 | 48 967 | −0,37 | 26,99 | −4 966 | 1 321 619 | |
2015-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 500 | 3 007 | −33,28 | |||
2015-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 500 | 48 783 | −2,98 | 110,06 | −165 092 | 5 369 120 | |
2015-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | −1 500 | 50 283 | −2,90 | 26,99 | −40 485 | 1 357 138 | |
2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 820 | 12 071 | −13,10 | |||
2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −180 | 4 507 | −3,84 | |||
2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 48 783 | −3,94 | 98,59 | −197 180 | 4 809 516 | |
2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | −1 820 | 50 783 | −3,46 | 40,56 | −73 819 | 2 059 758 | |
2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | −180 | 48 963 | −0,37 | 26,99 | −4 858 | 1 321 511 | |
2015-09-30 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 30 000 | 30 000 | |||||
2015-09-30 | 3 | ALDR |
ALDER BIOPHARMACEUTICALS INC
No securities are beneficially owned. |
0 | ||||||||
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | 2 500 | 5 000 | 100,00 | ||||
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −1 349 | 48 783 | −2,69 | 117,86 | −158 993 | 5 749 564 | |
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 500 | 50 132 | 5,25 | ||||
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 4 687 | −51,62 | |||
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 48 783 | −3,94 | 120,00 | −240 000 | 5 853 960 | |
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 000 | 50 783 | −5,58 | 118,64 | −355 920 | 6 024 895 | |
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 53 783 | 10,25 | 26,99 | 134 950 | 1 451 603 | |
2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 9 687 | −23,65 | |||
2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 000 | 47 632 | −5,93 | 118,24 | −354 729 | 5 632 151 | |
2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 3 000 | 50 632 | 6,30 | 26,99 | 80 970 | 1 366 558 | |
2015-06-22 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 12 687 | −44,08 | |||
2015-06-22 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −10 000 | 47 632 | −17,35 | 120,00 | −1 200 025 | 5 715 959 | |
2015-06-22 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 10 000 | 57 632 | 20,99 | 26,99 | 269 900 | 1 555 488 | |
2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 706 | 13 891 | −10,94 | |||
2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 294 | 22 687 | −5,40 | |||
2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 000 | 47 632 | −5,93 | 113,09 | −339 278 | 5 386 822 | |
2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 294 | 50 632 | 2,62 | 26,99 | 34 925 | 1 366 558 | |
2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 706 | 49 338 | 3,58 | 40,56 | 69 195 | 2 001 149 | |
2015-05-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 074 | 26 566 | −13,30 | |||
2015-05-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 926 | 15 597 | −10,99 | |||
2015-05-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −6 000 | 47 632 | −11,19 | 110,00 | −660 020 | 5 239 682 | |
2015-05-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 926 | 53 632 | 3,72 | 40,56 | 78 119 | 2 175 314 | |
2015-05-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 4 074 | 51 706 | 8,55 | 80,65 | 328 568 | 4 170 089 | |
2015-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −5 000 | 7 500 | −40,00 | ||||
2015-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −2 807 | 47 632 | −5,57 | 103,85 | −291 507 | 4 946 583 | |
2015-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 50 439 | 11,00 | ||||
2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 30 640 | −6,13 | |||
2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 45 439 | −4,22 | 103,18 | −206 365 | 4 688 510 | |
2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 47 439 | 4,40 | 80,65 | 161 300 | 3 825 955 | |
2015-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −205 | 32 640 | −0,62 | |||
2015-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −795 | 32 845 | −2,36 | |||
2015-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 000 | 45 439 | −2,15 | 100,00 | −100 000 | 4 543 900 | |
2015-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 205 | 46 439 | 0,44 | 80,65 | 16 533 | 3 745 305 | |
2015-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 795 | 46 234 | 1,75 | 80,65 | 64 117 | 3 728 772 | |
2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 000 | 33 640 | −2,89 | |||
2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 000 | 45 439 | −2,15 | 98,04 | −98 044 | 4 455 039 | |
2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 000 | 46 439 | 2,20 | 80,65 | 80 650 | 3 745 305 | |
2015-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 34 640 | −5,46 | |||
2015-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 45 439 | −4,22 | 104,18 | −208 364 | 4 733 930 | |
2015-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 47 439 | 4,40 | 80,65 | 161 300 | 3 825 955 | |
2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −16 157 | 45 439 | −26,23 | 103,84 | −1 677 743 | 4 718 386 | |
2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 19 200 | 61 596 | 45,29 | ||||
2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 7 840 | 42 396 | 22,69 | ||||
2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 248 | 34 556 | 0,72 | 85,61 | 21 232 | 2 958 408 | |
2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 36 640 | −5,18 | |||
2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 34 308 | −5,51 | 106,15 | −212 310 | 3 641 959 | |
2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 36 308 | 5,83 | 80,65 | 161 300 | 2 928 240 | |
2015-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
A - Award | 44 300 | 44 300 | |||||
2015-01-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −717 | 17 523 | −3,93 | |||
2015-01-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −283 | 23 981 | −1,17 | |||
2015-01-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 000 | 34 308 | −2,83 | 100,88 | −100 880 | 3 461 008 | |
2015-01-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 283 | 35 308 | 0,81 | 26,99 | 7 638 | 952 963 | |
2015-01-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 717 | 35 025 | 2,09 | 40,56 | 29 082 | 1 420 614 | |
2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 000 | 18 240 | −5,20 | |||
2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 000 | 34 308 | −2,83 | 95,05 | −95 050 | 3 260 975 | |
2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 000 | 35 308 | 2,91 | 40,56 | 40 560 | 1 432 092 | |
2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 19 240 | −9,42 | |||
2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 34 308 | −5,51 | 100,02 | −200 031 | 3 431 325 | |
2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 36 308 | 5,83 | 40,56 | 81 120 | 1 472 652 | |
2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −4 800 | 12 500 | −27,75 | ||||
2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | 2 736 | 34 308 | 8,67 | 109,72 | 300 194 | 3 764 274 | |
2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 4 800 | 37 044 | 14,89 | ||||
2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 21 240 | −12,38 | |||
2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 000 | 32 244 | −8,51 | 112,46 | −337 380 | 3 626 160 | |
2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 3 000 | 35 244 | 9,30 | 40,56 | 121 680 | 1 429 497 | |
2014-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 24 240 | −7,62 | |||
2014-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 32 244 | −5,84 | 110,00 | −220 007 | 3 546 946 | |
2014-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 34 244 | 6,20 | 40,56 | 81 120 | 1 388 937 | |
2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 26 240 | −7,08 | |||
2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 32 244 | −5,84 | 106,39 | −212 785 | 3 430 526 | |
2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 34 244 | 6,20 | 40,56 | 81 120 | 1 388 937 | |
2014-09-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 28 240 | −6,61 | |||
2014-09-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 32 244 | −5,84 | 107,47 | −214 945 | 3 465 343 | |
2014-09-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 000 | 34 244 | 6,20 | 40,56 | 81 120 | 1 388 937 | |
2014-08-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 15 200 | −39,68 | ||||
2014-08-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −10 000 | 32 244 | −23,67 | 106,16 | −1 061 618 | 3 423 081 | |
2014-08-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 10 000 | 42 244 | 31,01 | 19,08 | 190 850 | 806 227 | |
2014-08-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 259 | 32 244 | 0,81 | 21,94 | 5 684 | 707 591 | |
2014-08-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 728 | 24 264 | −40,81 | |||
2014-08-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 303 | 31 985 | −3,91 | 92,04 | −119 930 | 2 943 954 | |
2014-08-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 425 | 33 288 | −31,67 | 91,54 | −1 411 951 | 3 047 067 | |
2014-08-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 16 728 | 48 713 | 52,30 | 26,99 | 451 489 | 1 314 764 | |
2014-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −2 500 | 17 300 | −12,63 | ||||
2014-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −1 220 | 31 985 | −3,67 | 91,50 | −111 630 | 2 926 628 | |
2014-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 500 | 33 205 | 8,14 | ||||
2014-07-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 728 | 40 992 | −28,98 | |||
2014-07-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 728 | 30 705 | −35,27 | 86,45 | −1 446 074 | 2 654 334 | |
2014-07-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 16 728 | 47 433 | 54,48 | 26,99 | 451 489 | 1 280 217 | |
2014-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 728 | 57 720 | −22,47 | |||
2014-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 000 | 30 705 | −6,12 | 80,89 | −161 772 | 2 483 608 | |
2014-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 020 | 32 705 | −5,82 | 80,04 | −161 690 | 2 617 855 | |
2014-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −12 708 | 34 725 | −26,79 | 79,10 | −1 005 182 | 2 746 692 | |
2014-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 16 728 | 47 433 | 54,48 | 26,99 | 451 489 | 1 280 217 | |
2014-05-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −5 000 | 19 800 | −20,16 | ||||
2014-05-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −2 857 | 18 433 | −13,42 | 79,76 | −227 874 | 1 470 216 | |
2014-05-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 21 290 | 30,69 | ||||
2014-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 728 | 74 448 | −18,35 | |||
2014-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 728 | 28 562 | −36,94 | 78,80 | −1 318 143 | 2 250 646 | |
2014-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 16 728 | 45 290 | 58,57 | 26,99 | 451 489 | 1 222 377 | |
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −8 824 | 91 176 | −8,82 | |||
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −7 904 | 0 | −100,00 | |||
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −6 328 | 28 562 | −18,14 | 70,20 | −444 205 | 2 004 958 | |
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −10 400 | 34 890 | −22,96 | 70,73 | −735 577 | 2 467 721 | |
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 8 824 | 45 290 | 24,20 | 26,99 | 238 160 | 1 222 377 | |
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 7 904 | 36 466 | 27,67 | 21,58 | 170 529 | 786 754 | |
2014-03-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 728 | 7 904 | −67,91 | |||
2014-03-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 728 | 28 562 | −36,94 | 79,32 | −1 326 833 | 2 265 484 | |
2014-03-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 16 728 | 45 290 | 58,57 | 21,58 | 360 907 | 977 132 | |
2014-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −11 280 | 28 562 | −28,31 | 79,92 | −901 498 | 2 282 675 | |
2014-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 24 000 | 39 842 | 151,50 | ||||
2014-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −30 000 | 40 000 | −42,86 | ||||
2014-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −69 000 | 0 | −100,00 | ||||
2014-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −99 000 | 15 842 | −86,21 | 83,55 | −8 271 935 | 1 323 677 | |
2014-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 30 000 | 114 842 | 35,36 | 24,90 | 747 150 | 2 860 140 | |
2014-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 69 000 | 84 842 | 435,55 | 23,60 | 1 628 400 | 2 002 271 | |
2014-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 709 | 15 842 | 4,69 | 21,94 | 15 559 | 347 651 | |
2014-02-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 728 | 24 632 | −40,44 | |||
2014-02-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 728 | 15 133 | −52,50 | 79,10 | −1 323 198 | 1 197 032 | |
2014-02-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 16 728 | 31 861 | 110,54 | 21,58 | 360 907 | 687 401 | |
2014-02-12 | 3 | GILD |
GILEAD SCIENCES INC
Common Stock |
17 994 | ||||||||
2014-02-12 | 3 | GILD |
GILEAD SCIENCES INC
Common Stock |
24 733 | ||||||||
2014-02-12 | 3 | GILD |
GILEAD SCIENCES INC
Common Stock |
17 805 | ||||||||
2014-02-12 | 3 | GILD |
GILEAD SCIENCES INC
Common Stock |
17 994 | ||||||||
2014-02-12 | 3 | GILD |
GILEAD SCIENCES INC
Common Stock |
24 733 | ||||||||
2014-02-12 | 3 | GILD |
GILEAD SCIENCES INC
Common Stock |
17 805 |